Literature DB >> 26593872

Distribution and accumulation of 10 nm silver nanoparticles in maternal tissues and visceral yolk sac of pregnant mice, and a potential effect on embryo growth.

Carlye A Austin1, Georgia K Hinkley2, Anurag R Mishra3, Qin Zhang3, Thomas H Umbreit3, Martha W Betz3, Bridget E Wildt3, Brendan J Casey3, Sabine Francke-Carroll4, Saber M Hussain5, Stephen M Roberts2, Ken M Brown1, Peter L Goering3.   

Abstract

We examined the distribution of silver in pregnant mice and embryos/fetuses following intravenous injections of 10 nm silver nanoparticles (AgNPs) or soluble silver nitrate (AgNO3) at dose levels of 0 (citrate buffer control) or 66 µg Ag/mouse to pregnant mice on gestation days (GDs) 7, 8 and 9. Selected maternal tissues and all embryos/fetuses from control, AgNP- and AgNO3-treated groups on GD10 and control and AgNP-treated groups on GD16 were processed for the measurement of silver concentrations, intracellular AgNP localization, histopathology and gross examination of tissue morphology. Inductively-coupled plasma mass spectrometry revealed silver in all examined tissues following either AgNP or AgNO3 treatment, with highest concentrations of silver in maternal liver, spleen and visceral yolk sac (VYS), and lowest concentrations in embryos/fetuses. For VYS, mean silver concentration following AgNO3 treatment (4.87 ng Ag/mg tissue) was approximately two-fold that following AgNP treatment (2.31 ng Ag/mg tissue); for all other tissues examined, mean silver concentrations following either AgNP or AgNO3 treatment were not significantly different from each other (e.g. 2.57 or 2.84 ng Ag/mg tissue in maternal liver and 1.61 or 2.50 ng Ag/mg tissue in maternal spleen following AgNP or AgNO3 treatment, respectively). Hyperspectral imaging revealed AgNP aggregates in maternal liver, kidney, spleen and VYS from AgNP-treated mice, but not AgNO3-treated mice. Additionally, one or more embryos collected on GD10 from eight of ten AgNP-treated mice appeared small for their age (i.e. Theiler stage 13 [GD8.5] or younger). In the control group (N = 11), this effect was seen in embryos from only one mouse. In conclusion, intravenous injection of 10 nm AgNPs to pregnant mice resulted in notable silver accumulation in maternal liver, spleen and VYS, and may have affected embryonic growth. Silver accumulation in embryos/fetuses was negligible.

Entities:  

Keywords:  Development; fetus; nanoparticles; nanosilver; pregnancy; toxicity

Mesh:

Substances:

Year:  2015        PMID: 26593872     DOI: 10.3109/17435390.2015.1107143

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  22 in total

Review 1.  Design of nanomaterials for applications in maternal/fetal medicine.

Authors:  N'Dea S Irvin-Choy; Katherine M Nelson; Jason P Gleghorn; Emily S Day
Journal:  J Mater Chem B       Date:  2020-05-26       Impact factor: 6.331

Review 2.  Targeted drug delivery for maternal and perinatal health: Challenges and opportunities.

Authors:  Anjali Sharma; Nirnath Sah; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2021-08-26       Impact factor: 17.873

Review 3.  Safety and Toxicity Implications of Multifunctional Drug Delivery Nanocarriers on Reproductive Systems In Vitro and In Vivo.

Authors:  Anas Ahmad
Journal:  Front Toxicol       Date:  2022-06-15

4.  Disposition of intravenously or orally administered silver nanoparticles in pregnant rats and the effect on the biochemical profile in urine.

Authors:  Timothy R Fennell; Ninell P Mortensen; Sherry R Black; Rodney W Snyder; Keith E Levine; Eric Poitras; James M Harrington; Christopher J Wingard; Nathan A Holland; Wimal Pathmasiri; Susan C J Sumner
Journal:  J Appl Toxicol       Date:  2016-10-03       Impact factor: 3.446

5.  Acute intravenous exposure to silver nanoparticles during pregnancy induces particle size and vehicle dependent changes in vascular tissue contractility in Sprague Dawley rats.

Authors:  A K Vidanapathirana; L C Thompson; M Herco; J Odom; S J Sumner; T R Fennell; J M Brown; C J Wingard
Journal:  Reprod Toxicol       Date:  2017-11-21       Impact factor: 3.143

6.  The Effects of Chronic Exposure to Ambient Traffic-Related Air Pollution on Alzheimer's Disease Phenotypes in Wildtype and Genetically Predisposed Male and Female Rats.

Authors:  Kelley T Patten; Anthony E Valenzuela; Christopher Wallis; Elizabeth L Berg; Jill L Silverman; Keith J Bein; Anthony S Wexler; Pamela J Lein
Journal:  Environ Health Perspect       Date:  2021-05-10       Impact factor: 9.031

7.  Biodistribution, cardiac and neurobehavioral assessments, and neurotransmitter quantification in juvenile rats following oral administration of aluminum oxide nanoparticles.

Authors:  Ninell P Mortensen; Maria Moreno Caffaro; Purvi R Patel; Rodney W Snyder; Scott L Watson; Shyam Aravamudhan; Stephanie A Montgomery; Timothy Lefever; Susan J Sumner; Timothy R Fennell
Journal:  J Appl Toxicol       Date:  2020-12-02       Impact factor: 3.628

8.  Effects of developmental exposure to silver in ionic and nanoparticle form: A study in rats.

Authors:  Mohammad Charehsaz; Karin Sørig Hougaard; Hande Sipahi; Asiye Işın Doğan Ekici; Çiğdem Kaspar; Mustafa Culha; Ülkü Ündeğer Bucurgat; Ahmet Aydin
Journal:  Daru       Date:  2016-10-06       Impact factor: 3.117

9.  Oocyte exposure to ZnO nanoparticles inhibits early embryonic development through the γ-H2AX and NF-κB signaling pathways.

Authors:  Jing Liu; Yong Zhao; Wei Ge; Pengfei Zhang; Xinqi Liu; Weidong Zhang; Yanan Hao; Shuai Yu; Lan Li; Meiqiang Chu; Lingjiang Min; Hongfu Zhang; Wei Shen
Journal:  Oncotarget       Date:  2017-06-27

10.  The Potential of Nanotechnology in Medically Assisted Reproduction.

Authors:  Mariana H Remião; Natalia V Segatto; Adriana Pohlmann; Silvia S Guterres; Fabiana K Seixas; Tiago Collares
Journal:  Front Pharmacol       Date:  2018-01-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.